We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TACT icon
4601
Transact Technologies
TACT
$53.2M
$10K ﹤0.01%
+755
New +$9.62K
TCI icon
4602
Transcontinental Realty Investors
TCI
$352M
$10K ﹤0.01%
307
-825
-73% -$21.3K
TSQ icon
4603
Townsquare Media
TSQ
$106M
$10K ﹤0.01%
778
+379
+95% +$4.51K
TWIN icon
4604
Twin Disc
TWIN
$329M
$10K ﹤0.01%
725
+408
+129% +$5.08K
YCBD icon
4605
cbdMD
YCBD
$5.32M
$10K ﹤0.01%
9
+2
+29% +$2.39K
ZDGE icon
4606
Zedge
ZDGE
$38.6M
$10K ﹤0.01%
552
+549
+18,300% +$7.68K
FFNW
4607
DELISTED
First Financial Northwest, Inc
FFNW
$10K ﹤0.01%
+676
New +$9.63K
SBOW
4608
DELISTED
SilverBow Resources, Inc.
SBOW
$10K ﹤0.01%
+418
New +$6.36K
WTER
4609
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$10K ﹤0.01%
434
-1,130
-72% -$20.7K
ORTX
4610
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$10K ﹤0.01%
213
-14
-6% -$780
PLXP
4611
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$10K ﹤0.01%
725
+684
+1,668% +$8.1K
AGRX
4612
DELISTED
Agile Therapeutics
AGRX
$10K ﹤0.01%
4
-24
-86% -$79.1K
OTIC
4613
DELISTED
Otonomy, Inc.
OTIC
$10K ﹤0.01%
4,630
-77,141
-94% -$178K
MN
4614
DELISTED
MANNING & NAPIER, INC.
MN
$10K ﹤0.01%
+1,290
New +$9.76K
USAK
4615
DELISTED
USA Truck Inc
USAK
$10K ﹤0.01%
622
-2,655
-81% -$43.2K
AFI
4616
DELISTED
Armstrong Flooring, Inc.
AFI
$10K ﹤0.01%
1,636
+1,481
+955% +$8.5K
GWGH
4617
DELISTED
GWG Holdings, Inc
GWGH
$10K ﹤0.01%
1,262
-1,412
-53% -$9.59K
CLDB
4618
DELISTED
CORTLAND BNCP CRTLD OHIO
CLDB
$10K ﹤0.01%
+378
New +$9.14K
JAX
4619
DELISTED
J. Alexander's Holdings, Inc.
JAX
$10K ﹤0.01%
893
+769
+620% +$8.48K
PEI
4620
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$10K ﹤0.01%
270
+254
+1,588% +$8.28K
AC
4621
DELISTED
Associated Capital Group
AC
$9K ﹤0.01%
230
-1,266
-85% -$46K
CAPR icon
4622
Capricor Therapeutics
CAPR
$223M
$9K ﹤0.01%
1,829
+1,731
+1,766% +$7.33K
CSBR icon
4623
Champions Oncology
CSBR
$74.5M
$9K ﹤0.01%
846
-4,812
-85% -$48.8K
DAVA icon
4624
Endava
DAVA
$158M
$9K ﹤0.01%
75
-1,833
-96% -$177K
GNE icon
4625
Genie Energy
GNE
$367M
$9K ﹤0.01%
1,450
-9,562
-87% -$58.6K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.